Clinical Trial Update: Sublingual Versus Vaginal Misoprostol In Medical Treatment of First Trimestric Missed Miscarriage [Phase 3]

View source ↗

Summary

A Phase 3 trial at Ain Shams University compared sublingual and vaginal misoprostol for medical management of first-trimester missed abortion and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Missed Abortion

Drugs mentioned

• Cytotec (misoprostol)

Snippet

Sponsor: Ain Shams University | Conditions: Missed Abortion | Phase 3 | Status: COMPLETED